Position in AZN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$188,302,303
New position
Shares Held
954,783
first reported quarter
Ownership
0.062%
of shares outstanding
% of Portfolio
4.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 10.334494853804477.ToString("F0")%
Shared 0.ToString("F0")%
None 89.66550514619553.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Generali Asset Management SPA SGR holds $342,656,021 across 9 Drug Manufacturers - General names. AZN ranks #1 (55.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
954,783 | $188,302,303 | |
| 2 | LLY |
ELI LILLY & Co
|
62,651 | $57,624,510 | |
| 3 | MRK |
Merck & Co., Inc.
|
284,084 | $34,172,464 | |
| 4 | AMGN |
Amgen Inc
|
50,205 | $17,664,629 | |
| 5 | ABBV |
AbbVie Inc.
|
80,486 | $17,504,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
252,642 | $15,322,737 | |
| 7 | BIIB |
Biogen Inc.
|
34,194 | $6,268,786 | |
| 8 | PFE |
Pfizer Inc
|
206,394 | $5,795,543 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $188,302,303 | 954,783 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||